PharmaBoardroom

Interview with Francisco Medone Crovetto, CEO, ITF-Labomed

Labomed was bought by Italfarmaco in 2009, but aside from that, what have been the main milestones and achievements of Labomed since its creation in…

Interview with Cesar Buendia Sardon, General Manager –…

Lilly’s portfolio ranges from products for cardiovascular diseases to neurological conditions. How has your portfolio developed in Chile? What…

Interview with Katia Trusich, Genreal Manager, Genzyme Chile

Genzyme was first established in Chile in 2004 but only opened its sales office in 2008, what was the rationale for the opening of the office at this…

Interview with Avi Meizler, President and Founder, Meizler…

There is little publicly available information on your personal history and the founding of Meizler. Can you share that story for our readers?…

Interview with Bruno Chassot, President, Zodiac Pharmaceuticals

What would you recommend in terms of increasing the competitiveness and growth of the Brazilian pharmaceutical industry? The Brazilian pharmaceutical…

Interview with Claudia Varela, General Manager Peru, Ecuador…

What is the role, significance, and importance of the Colombian market within the larger global strategy of Genzyme international? Colombia is a very…

Interview with Gustavo Mizraje, General Manager, Novo Nordisk…

Diabetes affects an estimated 6 million Brazilians, a figure which is expected to double by 2025, in line with many other developing nations. Like…

Interview with Claudio Coracini, General Manager, Specialty…

Minister Pimentel recently released the BrasilMaior plan, whose slogan is “Innovate to compete. Compete to grow.” How would you recommend…

Interview with Irena Rej, President, Chamber of Commerce…

The pharmaceutical industry market growth, including generics and originator drugs, is today steady and sustainable. The market size is over 5 billion…